Follow
Preeti Dubey
Title
Cited by
Cited by
Year
Dynamics of an SIR model with nonlinear incidence and treatment rate
B Dubey, P Dubey, US Dubey
Applications and Applied Mathematics: An International Journal (AAM) 10 (2), 5, 2015
642015
Role of media and treatment on an SIR model
B Dubey, P Dubey, D Uma S
Nonlinear Analysis: Modelling and Control 21 (2), 185–200, 2015
392015
Modeling the role of acquired immune response and antiretroviral therapy in the dynamics of HIV infection
P Dubey, US Dubey, B Dubey
Mathematics and Computers in Simulation 144, 120-137, 2018
262018
An SIR model with nonlinear incidence rate and Holling type III treatment rate
P Dubey, B Dubey, US Dubey
Applied Analysis in Biological and Physical Sciences, 63-81, 2016
232016
Modeling the intracellular pathogen-immune interaction with cure rate
B Dubey, P Dubey, US Dubey
Communications in Nonlinear Science and Numerical Simulation 38, 72-90, 2016
192016
A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C
C Koh, P Dubey, MAT Han, PJ Walter, HM Garraffo, P Surana, ...
Antiviral research 163, 149-155, 2019
72019
What is the optimal level of information dissemination during an epidemic?
M LASKOWSKI, P DUBEY, ME ALEXANDER, S COLLINSON, ...
BIOMAT 2014: International Symposium on Mathematical and Computational …, 2015
32015
Modeling time to cure after short-duration treatment for chronic HCV with daclatasvir, asunaprevir, beclabuvir and sofosbuvir: the FOURward study
B Deng, S Lou, P Dubey, O Etzion, K Chayam, SL Uprichard, M Sulkowski, ...
JOURNAL OF VIRAL HEPATITIS 25, 58-58, 2018
22018
Modeling hepatitis delta virus dynamics during ritonavir boosted lonafarnib treatment-the LOWR HDV-3 study
P Dubey, C Koh, P Surana, SL Uprichard, MAT Han, N Fryzek, D Kapuria, ...
Hepatology 66, 21A-21A, 2017
22017
Convergent matrix factorization based entire frame image processing
VK Subramanian, P Dubey
US Patent 9,311,897, 2016
22016
Understanding early HBV kinetics during infection and treatment in primary human hepatocytes: a data-driven mathematical modeling approach
P Dubey, Y Ishida, M Tsuge, M Yamao, C Tateno, SL Uprichard, H Dahari, ...
HEPATOLOGY 70, 178A-178A, 2019
12019
Pharmacokinetics and pharmacodynamics modeling of ritonavir boosted lonafarnib therapy in HDV patients: A phase 2 LOWR HDV-3 study
P Dubey, C Koh, P Surana, S Uprichard, MAT Han, N Fryzek, ...
Journal of Hepatology 68, S508, 2018
12018
Stability Analysis and simulation of deterministic models in epidemiology and immunology
P Dubey
BITS Pilani, 2016
12016
Optimal control for therapeutic drug treatment on a delayed model incorporating immune response
P DUBEY, B DUBEY, UMAS DUBEY
BIOMAT 2015: International Symposium on Mathematical and Computational …, 2016
12016
Modeling the dynamics of viral–host interaction during treatment of productively infected cells and free virus involving total immune response
P Dubey, US Dubey, B Dubey
Nonlinear Analysis: modeling and Control 26 (4), 678-701, 2021
2021
Mathematical modeling of early hepatitis D virus kinetics in transgenic-hNTCP mice
P Dubey, ES Dastgerdi, H Shanes, S Uprichard, A Berneshawi, H Dahari, ...
Journal of Hepatology 73, S837-S838, 2020
2020
Characterization of HBV kinetics during infection and treatment in primary human hepatocytes
Y Ishida, P Dubey, M Tsuge, M Yamao, C Tateno, S Uprichard, H Dahari, ...
JOURNAL OF HEPATOLOGY 70, E702-E702, 2019
2019
Modeling extracellular HBV DNA kinetics during infection and treatment in primary human hepatocytes
P Dubey
2019
Modeling in humanized mice and patients suggests that antihistamine chlorcyclizine HCl not only blocks HCV infection/entry but also viral production
P Dubey, C Koh, N Borochov, SL Uprichard, S Cotler, S He, M Imamura, ...
HEPATOLOGY 66, 630A-630A, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–19